ContraVirPharma

ContraVir Pharmaceuticals

ContraVir is a biopharmaceutical company focused on the clinical development of TXL™ and CRV431 to treat Hep B and Valnivudine™ to treat PHN.

Strategy:
Joined 3/2015

3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or

Introducing Litepaper, a newsletter by Stocktwits. Your lens into the world of crypto.
Join the conversation.This is where all the magic happens.